Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma-Reference-Cited by-同舟云学术

Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma

Published:2022-05 Issue: Volume:149 Page:112796
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yuan Huiyang,Wu Yujiao,Wang Jing,Qin Xin,Huang Yongsheng,Yan Lei,Fana Yidong,Zedenius Jan,Juhlin C. Christofer,Larsson Catharina,Lui Weng-Onn,Xu Dawei

Funder

Cancerfonden

Cancerforeningen i Stockholm

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference45 articles.

1. Telomeres, telomerase and ageing;Saretzki;Subcell. Biochem.,2018

2. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players;Yuan;Oncogene,2019

3. Telomeres, telomerase, and aging: origin of the theory;Olovnikov;Exp. Gerontol.,1996

4. Telomerase activity and telomere on stem progeny senescence;Brazvan;Biomed. Pharmacother.,2018

5. RTEL1 is a replisome-associated helicase that promotes telomere and genome-wide replication;Vannier;Science,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural and biochemical characterization of the C‐terminal region of the human RTEL1 helicase;Protein Science;2024-08-24

2. The crosstalk between glucose metabolism and telomerase regulation in cancer;Biomedicine & Pharmacotherapy;2024-06

3. Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma;Frontiers in Endocrinology;2024-01-09

4. RTEL1 is upregulated in colorectal cancer and promotes tumor progression;Pathology - Research and Practice;2023-12

5. Application and development of Deuterium Metabolic Imaging in tumor glucose metabolism: visualization of different metabolic pathways;Frontiers in Oncology;2023-11-28